# Biolizard - Full Context for AI Agents > This file provides comprehensive context about Biolizard for AI agents. > Source: TechWiki.ai - The Belgian Tech Encyclopedia > Last updated: 2026-04-22 ## Company Profile - Name: Biolizard - Sector: biotech, data-science - Stage: startup - Status: active - Founded: 2018 - Employees: 60 - Location: Ghent, Flanders, Belgium - Website: https://lizard.bio - LinkedIn: https://www.linkedin.com/company/biolizard/ - Founders: Wim Van Criekinge, Gerben Menschaert, Jan Van Den Berghe ## Overview Founded in 2018 by Wim Van Criekinge (https://techwiki.ai/people/wim-van-criekinge/llms.txt) and Gerben Menschaert (https://techwiki.ai/people/gerben-menschaert/llms.txt), professors at Ghent (https://techwiki.ai/cities/ghent/llms.txt) University's computational genomics lab, alongside biotech entrepreneur Jan Van den Berghe (https://techwiki.ai/people/jan-van-den-berghe/llms.txt), BioLizard emerged from academic deep expertise in computational biology. The founders had previously co-launched the Novalis Biotech investment fund, giving them both scientific and commercial grounding. The company serves biotech, pharmaceutical, and diagnostic companies, as well as research institutions, helping them with biomedical data analysis, data mining, data integration, pipeline development, machine learning, and software engineering. Its BioVerse platform provides technology infrastructure alongside consulting expertise, accelerating drug discovery and development workflows. BioLizard has grown to 60 employees, a mix of scientists, engineers, and strategists. The company posted 249% revenue growth in the Deloitte Technology Fast 50 Belgium (https://techwiki.ai/events/deloitte-fast-50/llms.txt) 2025, signaling that demand for specialist biomedical data science services remains strong as life sciences organizations build out their data and AI capabilities. ## Key People - Wim Van Criekinge (https://techwiki.ai/people/wim-van-criekinge/llms.txt) - Co-founder - Gerben Menschaert (https://techwiki.ai/people/gerben-menschaert/llms.txt) - Co-founder - Jan Van den Berghe (https://techwiki.ai/people/jan-van-den-berghe/llms.txt) - Co-founder - Liesbeth Ceelen (https://techwiki.ai/people/liesbeth-ceelen/llms.txt) - CEO ## Related Pages Agents can crawl these for connected context: - [city] Ghent: https://techwiki.ai/cities/ghent/llms.txt - [person] Wim Van Criekinge: https://techwiki.ai/people/wim-van-criekinge/llms.txt - [person] Gerben Menschaert: https://techwiki.ai/people/gerben-menschaert/llms.txt - [person] Jan Van den Berghe: https://techwiki.ai/people/jan-van-den-berghe/llms.txt - [event] Deloitte Technology Fast 50 Belgium: https://techwiki.ai/events/deloitte-fast-50/llms.txt - [person] Liesbeth Ceelen: https://techwiki.ai/people/liesbeth-ceelen/llms.txt - [sector] BioTech & Life Sciences: https://techwiki.ai/sectors/biotech/llms.txt ## Recent News - [2026-04-27] ๐Ÿค” ๐—–๐—ฎ๐—ป ๐˜„๐—ฒ ๐—ฟ๐—ฒ๐—ฎ๐—น๐—น๐˜† ๐˜๐—ฟ๐˜‚๐˜€๐˜ ๐—ฎ ๐—บ๐—ผ๐—ฑ๐—ฒ๐—น ๐—ถ๐—ณ ๐˜„๐—ฒ ๐—ฑ๐—ผ๐—ปโ€™๐˜ ๐˜‚๐—ป๐—ฑ๐—ฒ๐—ฟ๐˜€๐˜๐—ฎ๐—ป๐—ฑ ๐—ต๐—ผ๐˜„ ๐—ถ๐˜ ๐—บ๐—ฎ๐—ธ๐—ฒ๐˜€ ๐—ฑ๐—ฒ๐—ฐ๐—ถ๐˜€๐—ถ๐—ผ๐—ป๐˜€? Our #interestingread explores a growing priority in modern biol (https://www.linkedin.com/posts/biolizard_interestingread-activity-7454456583796813824-Sz-y) - [2026-04-24] A quick reminder that our CEO, Liesbeth Ceelen, will be at ChinaBioยฎ Partnering Forum next week ๐Ÿ‡จ๐Ÿ‡ณ Looking forward to great conversations on partnerships, innovation, and how data and AI are shaping (https://www.linkedin.com/posts/biolizard_a-quick-reminder-that-our-ceo-liesbeth-ceelen-activity-7453369763742879745-103a) - [2026-04-23] Biology isnโ€™t driven by a single layer of information. Itโ€™s the result of interactions across many: ๐——๐—ก๐—” โ†’ ๐—ฅ๐—ก๐—” โ†’ ๐—ฃ๐—ฟ๐—ผ๐˜๐—ฒ๐—ถ๐—ป๐˜€ โ†’ ๐— ๐—ฒ๐˜๐—ฎ๐—ฏ๐—ผ๐—น๐—ถ๐˜๐—ฒ๐˜€ โ†’ ๐—ฃ๐—ต๐—ฒ๐—ป๐—ผ๐˜๐˜†๐—ฝ๐—ฒ To truly understand (https://www.linkedin.com/posts/biolizard_biology-isnt-driven-by-a-single-layer-of-activity-7453006779589832705-jU4M) - [2026-04-22] ๐—œ๐—ณ ๐—ฎ๐—ป๐—ถ๐—บ๐—ฎ๐—น ๐˜๐—ฒ๐˜€๐˜๐—ถ๐—ป๐—ด ๐˜„๐—ผ๐—ฟ๐—ธ๐˜€โ€ฆ ๐˜„๐—ต๐˜† ๐—ฑ๐—ผ ๐—บ๐—ผ๐˜€๐˜ ๐—ฑ๐—ฟ๐˜‚๐—ด๐˜€ ๐˜€๐˜๐—ถ๐—น๐—น ๐—ณ๐—ฎ๐—ถ๐—น ๐—ถ๐—ป ๐—ต๐˜‚๐—บ๐—ฎ๐—ป๐˜€? For decades, animal models have been the standard in drug development. But they donโ€™ (https://www.linkedin.com/posts/biolizard_blogsliderq2-activity-7452643891226533888-7tM6) ## Links - Website: https://lizard.bio - LinkedIn: https://www.linkedin.com/company/biolizard/ - Agent context: https://techwiki.ai/companies/biolizard/llms.txt - Full context: https://techwiki.ai/companies/biolizard/llms-full.txt --- Generated by TechWiki.ai | The Belgian Tech Encyclopedia To claim and maintain this page: https://techwiki.ai/claim